A5000590257- Congenital Heart Disease Studies
- Cardiac Structural Anomalies and Repair
- Cardiac Arrhythmias and Treatments
- Tracheal and airway disorders
- Cardiac Valve Diseases and Treatments
- Aortic Disease and Treatment Approaches
- Coronary Interventions and Diagnostics
- Mechanical Circulatory Support Devices
- Coronary Artery Anomalies
- Cardiac pacing and defibrillation studies
- Infective Endocarditis Diagnosis and Management
- Management of metastatic bone disease
- Uterine Myomas and Treatments
- Trauma Management and Diagnosis
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Viral Infections and Immunology Research
- Cardiac and Coronary Surgery Techniques
- Pericarditis and Cardiac Tamponade
- Endometriosis Research and Treatment
- Organ Transplantation Techniques and Outcomes
- Ultrasound in Clinical Applications
- Healthcare and Venom Research
- Transplantation: Methods and Outcomes
- Cardiovascular and Diving-Related Complications
The University of Melbourne
2014-2021
Murdoch Children's Research Institute
2014-2021
Royal Children's Hospital
2014-2021
The Royal Melbourne Hospital
2018-2019
Royal Prince Alfred Hospital
2011-2018
The University of Sydney
2011
Nieuwegein Fonds
2011
Queen Elizabeth Hospital
2011
Baird Institute
2010-2011
The Ross procedure has demonstrated excellent results when performed in patients with aortic stenosis or mixed valve disease [aortic and regurgitation (AR)]. However, due to its reported risk of late reoperation, it is not recommended under current guidelines for presenting bicuspid pure AR. We have analysed our own light this recommendation. Between 1993 2016, 129 consecutive a mean age 34.7 ± 10.6 years (range 16–64 years) presented AR underwent the procedure. Patients were reviewed...
To investigate the benefits of a strategy early Fontan conversion. Using Australia and New Zealand Registry, retrospective analysis their long-term follow-up data was performed. Between 1990 2014, total 39 patients underwent surgical conversion in 6 centres at median age 23.8 years (IQR: 19.3–28.2), 18.7 ± 5.0 post-Fontan. One centre tended to perform earlier: interval since first documented arrhythmia 2.9 4.0 vs 4.2 years, average NYHA Class 2 0.4 3 0.9 ( P = 0.008), mean number preop...
The specific outcomes of patients with pulmonary atresia intact ventricular septum late after Fontan palliation are unknown. Patients smaller right ventricles and myocardial sinusoids known to have worse survival in the first years life. Whether potential for coronary ischaemia affects long-term these is still unknown.All who underwent procedure from 1984 2016 Australia New Zealand were identified, preoperative, perioperative follow-up data collected.Late available 120 patients. median...
The capacity and limitations of ventricular assist device (VAD) support in single-ventricle physiology remains poorly understood. We aimed to review our experience the use VAD circulation determine its feasibility this population.We reviewed with patients single ventricles over past 25 years. Fifty-seven received 64 runs between 1990 2015 at a median age 13 days [interquartile range (IQR) 4.1-99.4 days], which 55 were supported for post-cardiotomy failure. majority short-term support, while...
The mechanisms of attrition the Fontan population have been poorly characterised and it is unclear whether some deaths are potentially preventable. We analysed circumstances late death in patients with a circulation, special focus on identifying lesions amenable to intervention that may contributed decline their circulation.Between 1975 2018, total 105 from Bi-National Registry died beyond 1 year after completion, at median age 18.6 (IQR 13.8-26.0) years old, 12.7 6.0-19.3) completion.A...
This review identifies the predictors of late mortality and heart transplantation that remain relevant in contemporary population patients with a Fontan circulation, focusing on potential impact post-Fontan morbidities outlook these patients.A total 1561 who had survived operation Australia or New Zealand from 1975 to 2018 were included this review. Over median duration 11.4 years, there was 117 deaths (7%) 32 transplantations (2%). Freedom death at 10, 20 35 years post surgery 94% (95% CI...
Patients with hypoplastic left heart syndrome are at high risk of late adverse events after Fontan completion, but it is unclear whether their morphological characteristics influence these outcomes.Retrospective review the data from Australian and New Zealand Registry identified 185 patients who survived to hospital discharge completion. Their outcomes were reviewed identify predictors a particular focus on impact characteristics. All available echocardiographic parameters collected,...
"Pulmonary parenchymal endometriosis presenting as bilateral pneumothoraces." Journal of Obstetrics and Gynaecology, 31(5), pp. 452–453
Objectives: To investigate the benefits of a strategy early Fontan conversion. Methods: Between 1990 and 2014, total 39 patients underwent surgical conversion in 6 centres at median age 23.8 years (IQR: 19.5–28), 18.8 ± 5.2 post-Fontan. One centre tended to perform earlier: interval since first documented arrhythmia 2.9 4.0 vs 4.9 years, average NYHA class 2 0.45 3 0.85 (P = 0.008), mean number preoperative antiarrhythmics 1 0.36 0.64 0.05). Ten an extracardiac conduit only while 29 had...
Objective: To identify parameters predictive of death and failure in patients with an atrio-pulmonary connection Fontan. Methods: Retrospective analysis long-term follow-up data using the Australia New Zealand Fontan Registry Results: There were 245 surviving hospital discharge after atriopulmonary from 1975 to 1994. At latest follow-up, 54 pts died, 29 underwent heart transplantation 93 had (death, transplantation, conversion, protein losing enteropathy, severe left ventricular dysfunction...